Federal contract award
75N93019F00131
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93018D00010 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.2M |
| Current contract value | $2.2M |
| Potential contract value / ceiling | $3.6M |
| Start date | Feb 28, 2019 |
| Current end date | Apr 30, 2028 |
| Potential end date | Apr 30, 2028 |
| Latest award activity | Sep 2, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 2, 2026 | P00008 | $678.7K | PURPOSE: TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Aug 31, 2026 | P00007 | $-229.0K | PURPOSE: TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Apr 30, 2026 | P00006 | $0 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 |
| Sep 11, 2024 | P00005 | $-148.2K | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 |
| Aug 29, 2024 | P00004 | $-61.9K | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 |
| Jun 12, 2024 | P00003 | $0 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 |
| Apr 5, 2021 | P00002 | $666.4K | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 |
| Jun 11, 2019 | P00001 | $654.5K | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; TO V3 OBRA--2 BASE TASK ORDER FUNDING; BIOD CAN 8470038 $642,953 |
| Feb 28, 2019 | 0 | $643.0K | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 |
Estimated positioning window
Apr 30, 2027 – Oct 30, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2028-04-30 (546 days from calculation)
- +25 points
- 103 historical awards in this buyer and category group
- +15 points
- 9 recorded award transactions
- +10 points
- Latest award action: 2026-09-02
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.